| 1 |
22508302 | The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP. | 2012 Jul |
1 |
| 2 |
22004608 | Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers. | 2011 Dec 15 |
1 |
| 3 |
20607366 | In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice. | 2010 Oct |
6 |
| 4 |
19732493 | Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice. | 2009 |
1 |
| 5 |
18799806 | N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk. | 2008 Dec |
2 |
| 6 |
17093006 | Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2. | 2007 Feb |
2 |
| 7 |
17785426 | Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. | 2007 Dec |
1 |
| 8 |
15709111 | The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin. | 2005 May |
8 |